32548-10-0

Basic information

• Product Name: 4-chloro-3-(methylsulfonyl)-5-nitrobenzoic acid
• Synonyms: 4-chloro-3-(methylsulfonyl)-5-nitrobenzoic acid
• CAS NO: 32548-10-0
• Molecular Weight: 279.658
• Mol File: 32548-10-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-chloro-3-(methylsulfonyl)-5-nitrobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chloro-3-(methylsulfonyl)-5-nitrobenzoic acid(32548-10-0)
• EPA Substance Registry System: 4-chloro-3-(methylsulfonyl)-5-nitrobenzoic acid(32548-10-0)

Safety Data

• Hazardous Substances Data: 32548-10-0(Hazardous Substances Data)

Upstream product

• 200423-20-7 4-Chloro-3-hydroxysulfinylbenzoic acid 
• 2494-79-3 4-chloro-3-(chlorosulfonyl)benzoic acid 
• 51522-07-7 3-methylsulphonyl-4-chlorobenzoic acid 

Downstream Products

• 51522-19-1 3-methylsulfonyl-4-chloro-5-aminobenzoic acid 
• 1431501-03-9 3-(methylsulfonyl)-4-phenoxy-5-(piperidin-1-yl)benzoic acid 
• 1431501-05-1 3-(methylsulfonyl)-4-phenoxy-5-(2,2,2-trifluoroethylamino)benzoic acid 
• 1431501-23-3 N,N-dibutyl-3-(methylsulfonyl)-5-morpholino-2-phenoxyaniline 
• 1431501-27-7 3-(dibutylamino)-N,5-bis(methylsulfonyl)-4-phenoxybenzamide 
• 1431504-98-1 methyl 3-(methylsulfonyl)-5-nitro-4-phenoxybenzoate 
• 1431504-99-2 methyl 3-amino-5-(methylsulfonyl)-4-phenoxybenzoate 
• 1431505-00-8 methyl 3-(butylamino)-5-(methylsulfonyl)-4-phenoxybenzoate 
• 1431505-01-9 methyl 3-(methylsulfonyl)-4-phenoxy-5-(piperidin-1-yl)benzoate 
• 1431505-02-0 methyl 3-(methylsulfonyl)-4-phenoxy-5-(2,2,2-trifluoroethylamino)benzoate 
• 1431501-31-3 3-(dibutylamino)-5-(methylsulfonyl)-4-phenoxybenzoic acid sodium salt 
• 32548-16-6 3-(butylamino)-5-(methylsulfonyl)-4-phenoxybenzoic acid 
• 1431501-01-7 3-(dibutylamino)-5-(methylsulfonyl)-4-phenoxybenzamide 
• 1431501-02-8 (3-(dibutylamino)-5-(methylsulfonyl)-4-phenoxyphenyl)(4-morpholinyl)methanone 

Relevant articles and documents

2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE

Compounds are disclosed that have a formula represented by the following:(I) wherein Cy, L1 R1, R2a, R2b, R3, R4, n, and L2 are as described herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example addictive disorders, Alzheimer's Disease, anxiety disorders, ascites, autism, bipolar disorder, cancer, depression, endothelial corneal dystrophy, edema, epilepsy, glaucoma, Huntington's Disease, inflammatory pain, insomnia, ischemia, migraine, migraine with aura, migraine without aura, neuropathic pain, nociceptive neuralgia, nociceptive pain, ocular diseases, pain, itch, excessive itch, Pruritis, neuropathic pruritis, Parkinson's disease, personality disorders, postherpetic neuralgia, psychosis, schizophrenia, seizure disorders, tinnitus, and withdrawal syndromes.

3-Amino-5-sulfonylbenzoic acids

Aminobenzoic acids of the structure SPC1 Having saluretic and diuretic properties are described. These compounds are prepared by amidation of a 2-halo analog thereof or by alkylation of the free amino compound.